Navigation Links
Centocor R&D and University of Michigan Forge New Model for Academic/Industry Partnerships

MALVERN, Pa. March 19 /PRNewswire/ -- A new joint program launched by Centocor Research and Development, Inc. and the University of Michigan provides an innovative model for industry/academic fellowship programs. Centocor designed the program to continue to build and diversify the company's pipeline of talent while supporting postdoctoral researchers in populations that are traditionally underrepresented in the science and medical communities.

"Scientific excellence and diversity are key drivers for our success as a global pharmaceutical organization. Partnering with a leading research organization to foster the training of the next generation of scientific leaders is a key part of our strategy," said Miguel Barbosa, Ph.D., vice president, Discovery Research at Centocor R&D.

The program aims to forge strong relationships with African American, Hispanic, and Native American scientists who are working in the strategic areas of focus for Centocor.

"We believe the direct ties to our research interests make this program more strategic and collaborative than traditional industry/academic fellowship programs," Barbosa said. "This strategic link will help us build strong relationships with these talented individuals thus creating a robust pipeline of potential hires."

Under the program, research proposals developed jointly by University of Michigan and Centocor scientists are submitted to and reviewed by a joint committee of Centocor and Michigan representatives, who will select projects and evaluate their progress. Postdoctoral fellows recruited by the University of Michigan have the opportunity to work at both the University and at the Centocor campus and to work through scientific challenges with a mentor at each location.

Centocor R&D selected the University of Michigan with which to pilot the program, based on the high level of productivity past research collaborations have yielded, and may expand the program in the coming years to other academic partners.

Barbosa said, "We look forward to nurturing the development of underrepresented minority post doctoral trainees from University of Michigan and potentially other top-tier research organizations into the next generation of scientific leaders."

About Centocor Research and Development, Inc.

Centocor is dedicated to the research and development of treatments for a wide range of immune-mediated inflammatory disorders, such as arthritis, and inflammatory skin diseases, and for cancer, cardiovascular and metabolic and infectious diseases. Developed primarily through monoclonal antibody technology, Centocor helps physicians deliver innovative treatments to improve human health and restore patients' quality of life.

SOURCE Centocor Research and Development, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. FASgen, Inc. Announces Research and License Agreement With Centocor, Inc.
2. Biologic Drugs, Particularly Centocor/Janssen-Cilags Stelara and Abbott/Eisais Humira, will Drive the Psoriasis Drug Market to $5 Billion by 2017
3. MEDVERSATION(TM) Website Launched by Centocor to Facilitate Physician-Patient Dialogue About Drug Benefits and Risks
4. Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
5. Centocor, Schering-Plough Revise Agreement Covering REMICADE, Golimumab
6. Western Governors University Addresses Rising Demand for Healthcare IT Professionals with B.S. in Health Informatics
7. DeVry University announces Employment Gap Scholarship program to aid displaced workers
8. University of Notre Dame Chooses Latest Technology From Carestream Molecular Imaging For Disease Research
9. University of Pennsylvania researchers find that the unexpected is a key to human learning
10. NorthShore University HealthSystem Launches Diabetes Outreach Program for Lake County's Medically Underserved
11. Dallas To Host Intensive Norvax University Insurance Agent Sales Training and Web Marketing Conference on March 26
Post Your Comments:
(Date:11/24/2015)... ... ... Charitable giving is at its peak during the holidays. In fact, ... the year totalling over $358 billion in 2014. With more than 1.5 million ... individuals who want to “give back” during the holidays. , “With so many charities ...
(Date:11/24/2015)... ... November 24, 2015 , ... The hospitals ... to several aspects of orthopedic care. They have received recognition for excellence from ... orthopedic care. , Becker's Hospital Review selected hospitals for inclusion based on ...
(Date:11/24/2015)... Port Richey, FL (PRWEB) , ... November 24, 2015 , ... ... it deems a growing epidemic as deaths from prescription opioids in the United States ... heroin and cocaine. In 2013 alone, opioids were involved in 37 percent of all ...
(Date:11/24/2015)... ... November 24, 2015 , ... Serenity Point Rehabilitation, a holistic treatment center for ... with some of the staff members at their recovery center. The videos highlight some ... as some of the things that make their recovery program so unique. , “Making ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... award at Cleveland University-Kansas City (CU-KC), in Overland Park, Kansas. Benson, ... Chiropractor and University President Carl S. Cleveland III on October 16. , “Katie ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... BOULDER, Colo. , Nov. 24, 2015 /PRNewswire/ ... announced that its Chief Executive Officer, Ron ... Annual Healthcare Conference in New York.  The public ... a webcast on the Array BioPharma website.Event:Piper Jaffray ... OfficerDate:  , Wednesday, December 2, 2015Time:1:30 p.m. Eastern ...
(Date:11/24/2015)... Nueva York , 24 de noviembre de ... del Avery Breathing Pacemaker System, se complace anunciar ... Ph.D. como consultor clínico. ... Foto -   ... Jonzon es un fisiólogo y consultor en neonatología ...
(Date:11/24/2015)... --> --> ... by Product Type (Bone Graft, Bine Graft Substitute, Platelet Rich ... Lumbar Interbody Fusion), End User, and Geography - Global Forecast ... at $1.90 Billion in 2014 and is expected to reach ... the forecast period of 2015 to 2020. Browse ...
Breaking Medicine Technology: